Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Trained dogs detect thyroid cancer with great accuracy
Dog nose
“What we have done, no one has attempted to do. We have taken the next step by asking the dog to tell us whether or not cancer exists before the medical diagnostic system does."

Finding described as a 'tremendous advance'

Scent-trained dogs can sniff-out thyroid cancer with almost 90 per cent accuracy, according to research by the University of Arkansas for Medical Sciences (UAMS).

Presenting their findings at the Endocrine Society's ENDO 2015 conference earlier this month, the researchers said that having a technique with which to detect thyroid cancer to such a high degree of certainty would be a 'tremendous advance'.

They hope that the finding will lead to cost savings in diagnoses and the prevention of unnecessary surgeries.

It is also hoped that the method could be transported to under-served areas where traditional methods of biopsy and ultrasound are unavailable.

Furthermore, the researchers believe the training could potentially be used in diagnoses of other cancers such as ovarian, breast, kidney, bladder and prostate.

Detecting a diagnosis thyroid cancer can be difficult, because it's often looking for a very small number of occurrences in a very large background of benign nodules. It is also very difficult to say that a patient is cancer free after surgery.

The study took dogs already trained for scent detection and imprinted them with fresh tissue taken from patients diagnoses with papillary thyroid cancer.

The dogs were then presented with urine samples from patients, some with thyroid cancer and some with benign modules, and asked to indicate whether each sample had thyroid cancer or not.

Their results were compared to a surgical pathology diagnosis and matched in 30 out of 34 cases - or 88.2 per cent accuracy.

Commenting on the study, lead author Dr Arny Ferrano said: “What we have done, no one has attempted to do. We have taken the next step by asking the dog to tell us whether or not cancer exists before the medical diagnostic system does. We wanted to see, can the doctor utilise the dog to help diagnose cancer?"

So far, the results have led the researchers believe the answer to be 'yes'.

“We’ve all looked at it from a skeptical, scientific standpoint, but the data just keeps leading us to the fact that this has remarkable clinical potential,” said Ferrano.

Up to now, the team have used what are known as 'general source' dogs, or strays that have been trained in scent detection methods. They now plan to work with researchers at Auburn University's Canine Performance Sciences programme to teach and imprint dogs that have been specifically bred for medical detection. 

Become a member or log in to add this story to your CPD history

Regional Representatives nominations sought

News Story 1
 Seven new regional representatives are being sought by the British Veterinary Association (BVA) to speak for vets from those regions and to represent their views to BVA Council.

The opportunities are available in in the North-East, Yorkshire & Humber, East Midlands, West Midlands, London, Wales, and Northern Ireland. Representatives from all sectors of the veterinary profession are urged to apply.

BVA president Daniella Dos Santos, said: "Our regional representatives are integral to that mission and to the activities of Council - contributing to effective horizon scanning on matters of veterinary policy and providing an informed steer to BVA’s Policy Committee.” 

Click here for more...
News Shorts
Livestock Antibody Hub receives funding boost

The Pirbright Institute has received US $5.5 million from the Bill and Melinda Gates Foundation to form a Livestock Antibody Hub aimed at supporting animal and human health. The work will bring together researchers from across the UK utilise research outcomes in livestock disease and immunology.

Dr Doug Brown, chief executive of the British Society for Immunology, commented: “The UK is a world leader in veterinary immunology research, and this transformative investment from the Bill & Melinda Gates Foundation will drive the next chapter of innovation in developing new treatments and prevention options against livestock diseases".